The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech ...

Recently, investors have worried about the impact of the U.S.’s import tariffs on corporate earnings. Certain companies that ...

To this end, CRISPR Therapeutics is currently managing five other clinical trials, with several more pre-clinical studies ...

Q1 2025 Earnings Call Transcript May 8, 2025 Operator: Good afternoon, and welcome to OmniAb, Inc. First quarter 2025 ...

About PDS Biotechnology PDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. The Company has initiated a pivotal clinical ...

Valneva (VALN) stock is in focus as the U.S. recommends a pause in the company's chikungunya vaccine Ixchiq in adults 60+ ...

What are the best Europe-focused ETFs right now? Seeking Alpha analysts Fred Piard and John Bowman weigh in. Fred Piard: ...

SAIC Mobility unveiled its plans on Friday; others like Mirxes, Insilico and CiDi revive their applications, according to ...

Businesses that are solid enough to perform well over extended periods, while consistently raising their payouts, are precisely what income investors should gravitate toward. Here are two corporations ...

UK investors have enjoyed spectacular returns in their Stocks and Shares ISA's over the past five years. Would could the next ...

Activist Commentary: Elliott is a very successful and astute activist investor. The firm's team includes analysts from ...

Professional analysts at Barclays Capital have reiterated their Buy ratings on these proven UK shares, so should investors ...